Abstract: The embodiments of the present disclosure relate to an ultrasonic flaw-detection system and an ultrasonic flaw-detection method. The ultrasonic flaw-detection system may include: an ultrasonic flaw-detection device configured to transmit an ultrasonic wave to a detection target, collect an ultrasonic echo wave reflected from the detection target, and then generate a signal data; a signal data preprocessor configured to preprocesses the signal data; a defect candidate group selection unit configured to select a defect candidate group based on the preprocessed signal data and generate defect candidate signal data based on the selection; an image data generator configured to generate image data based on the defect candidate signal data included in the defect candidate group; and a defect determination unit configured to determine whether there is a defect in the defect candidate group based on the image data.

Abstract: The present invention relates to a composition for gene manipulation for treating or improving a retinal dysfunction disease or a method using the same. More particularly, the present invention relates to a composition for gene manipulation including a guide nucleic acid capable of targeting a retinal function-forming gene and a method of treating or improving a disease caused by retinal dysfunction by artificially manipulating and/or correcting a retinal function-forming gene using the same.

Abstract: Provided is a method of preparing L-homoserine, the method including contacting an L-homoserine derivative with a solid acid catalyst.

Abstract: Provided are a method and apparatus for providing image playing rate information. The method including receiving, from a user terminal, a target image request signal, transmitting, to the user terminal, a target image in a first state or the target image in a second state, based on whether the target image request signal satisfies a specified standard, obtaining, from the user terminal, state information and image playing information of the target image for each specified time, and providing user-wise playing rate information of the target image, based on the state information and image playing information of the target image may be provided.

Abstract: This application relates to a movable apparatus for collecting and analyzing specimens. In one aspect, the movable apparatus includes a transport means configured to be moved independently and to maintain negative pressure therein by a negative pressure module, and a specimen collecting device arranged in the transport means and configured to collect a specimen under remote control by inserting a specimen collecting member into the nasal cavity of a testee who enters the transport means. The apparatus may also include a specimen transport device arranged in the transport means and configured to transport the specimen collecting member under remote control that has collected the specimen in one direction, and a specimen analysis device arranged in the transport means and configured to extract the specimen from the specimen collecting member that has been transported by the specimen transport device under remote control and to analyze the specimen.

Abstract: An embodiment electronic pedal apparatus includes a pedal housing and an accelerator pedal assembly and a brake pedal assembly coupled to the pedal housing and configured to move along different movement trajectories when the accelerator pedal assembly and the brake pedal assembly are operated. In an embodiment, the accelerator pedal assembly is compressed and moved upward when the accelerator pedal assembly is operated, and the brake pedal assembly is compressed and moved downward when the brake pedal assembly is operated.

Abstract: The present invention relates to an expression control composition for controlling the expression of a duplicate gene or a method using the same. In addition, the present invention relates to a method of treating or improving a disease caused by gene duplication using the expression control composition for controlling the expression of a duplicate gene.

Abstract: The present application relates to a composition and method for inhibiting Hepatitis B virus (HBV) proliferation.

Abstract: Provided is a platform for expressing a protein of interest by artificially manipulating the liver, and more particularly, to a platform for alleviating or treating a genetic disorder or improving a body function by inducing expression by inserting a transgene (e.g., a therapeutic gene) which can function or be expressed normally, into a high-expression secretory gene, instead of a disease gene which functions or is expressed abnormally. The high-expression secretory gene includes the HP or APOC3 gene. The transgene includes one that is highly expressed using a promoter in a hepatocyte genome and is secretory out of the cell.

Abstract: The present invention relates to a cytokine trimer domain in which a first monomer and a second monomer linked by linker (dimer) and a third monomer are coupled by a knob-into-hole and a novel type of fusion protein in which antibody and cytokine trimer domains are linked (receptor-antibody conjugated (cell) engager, RACE) prepared by replacing a constant region (Fc) of an antibody with the cytokine trimer domain, and RACE according to the present invention exhibits superior binding ability to the target receptor than the parent antibody as well as excellent simultaneous binding ability to the antigen and the target receptor, which can be usefully utilized as a bispecific pharmaceutical composition.

Abstract: An apparatus configured to manufacture a display device and a method of manufacturing a display device include a stage configured to place a process target object on an upper surface thereof; a bending head in contact with the process target object to bend the process target object; a distance measurement sensor installed above the stage to be movable in a horizontal direction; and a cylinder configured to adjust a vertical position of the bending head.

Abstract: A non-aqueous electrolyte and a lithium secondary battery including the same are disclosed herein. The non-aqueous electrolyte may be used in a high-voltage battery to achieve excellent life characteristics. In some embodiments, a non-aqueous electrolyte includes an organic solvent, a lithium salt, a compound represented by Formula 1, and a compound represented by Formula 2, wherein, when an amount of the compound represented by Formula 1 is X wt% and an amount of the compound represented by Formula 2 is Y wt % based on a total weight of the non-aqueous electrolyte, X and Y satisfy X+Y ? 5 and X ? Y, R1 is an unsaturated hydrocarbon group n is an integer of 1 or 2, and R2 is hydrogen, an unsubstituted or substituted alkyl group, or an unsubstituted or substituted alkoxy group.

Abstract: The present disclosure relates to a lithium secondary battery comprising a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and a non-aqueous electrolyte. The non-aqueous electrolyte includes an organic solvent, a lithium salt, a coumarin-based compound represented by [Chemical Formula 1], and a halogen-substituted cyclic carbonate, and the positive electrode active material includes a lithium manganese-rich oxide represented by [Chemical Formula 2].

Abstract: The present disclosure relates to a non-aqueous electrolyte including an organic solvent, a lithium salt, and a coumarin-based compound represented by the following Chemical Formula 1 and a lithium secondary battery including the non-aqueous electrolyte: in Chemical Formula 1, R is a substituent including one or more elements selected from the group consisting of C, O, N, B, S, P, Si, and F, and n is an integer of 1 to 6.

Abstract: The present disclosure relates to a method for preparing L-cysteine crystals, and L-cysteine crystals prepared by the method. Through the method for preparing L-cysteine crystals of the present disclosure, L-cysteine crystals can be obtained from a natural L-cysteine fermentation broth with a high recovery rate and/or purity without a chemical reaction or the use of an artificial synthetic compound.

Abstract: The present disclosure relates to method and apparatus for processing cross matching image based on deep learning.

Abstract: The present disclosure provides a display apparatus, a display panel and an electronic apparatus. The display apparatus comprises a display panel and a camera unit formed on a lower portion of the display panel, wherein the display panel includes a display area including a plurality of subpixels and a non-display area positioned on at least one side of the display area, the display area includes a first display area and a second display area overlapped with the camera unit, and the number of light emitting elements provided in a unit area of the first display area is greater than the number of light emitting elements provided in the unit area of the second display area.

Abstract: A display apparatus can include a display panel configured to display an image, a polarizing plate disposed on the display panel, a first film disposed on the polarizing plate, a liquid crystal layer disposed on the first film, and a second film disposed on the liquid crystal layer. Also, the liquid crystal layer can be disposed in a cover member and have a retardation of a quarter wave (?/4) to a half wave (?/2), and the liquid crystal layer can be spaced apart from the flexible display panel.

Abstract: According to an aspect of the present disclosure, a display device includes a substrate in which a plurality of sub pixels having different areas is defined; a plurality of light emitting elements each on a corresponding one of the plurality of sub pixels and includes an anode and a cathode; a first anode reset line which is connected to some of the plurality of sub pixels and outputs a first anode reset voltage to anodes of the some of the plurality of sub pixels; and a second anode reset line which is connected to remaining sub pixels of the plurality of sub pixels and outputs a second anode reset voltage to anodes of the remaining sub pixels. Accordingly, according to the present disclosure, different anode reset voltages are applied according to areas of the plurality of sub pixels so that the voltage deviation and the color variation of the anode according to the areas of the plurality of sub pixels may be reduced.

Abstract: A thin film deposition apparatus used to produce large substrates on a mass scale and improve manufacturing yield. The thin film deposition apparatus includes a deposition source; a first nozzle disposed at a side of the deposition source and including a plurality of first slits arranged in a first direction; a second nozzle disposed opposite to the first nozzle and including a plurality of second slits arranged in the first direction; and a barrier wall assembly including a plurality of barrier walls arranged in the first direction so as to partition a space between the first nozzle and the second nozzle.